Track Applied Dna Sciences's net income ($-66M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Loading...
Loading...
Applied Dna Sciences (APDN) currently reports a net income of $-66M as of June 2026. That compares with $-37M in the prior-year period — down 77.1% year over year. That is below the Materials sector average of $18B. Use the charts on this page to explore Applied Dna Sciences's net income history and peer comparisons.
Applied Dna Sciences's net income decreased from $-37M to $-66M — a 77.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Applied Dna Sciences's net income of $-66M is lower than the Materials sector average of $18B. That is roughly 100.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
Applied Dna Sciences reported $-66M in net income as of June 2026. That compares with $-37M in the prior-year period — down 77.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current net income of $-66M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Materials average is $18B. From there, open related valuation or income-statement pages for Applied Dna Sciences, and consider following APDN for alerts when major investors trade the stock.